Previous 10 | Next 10 |
Bank of Hawaii Corporation (BOH) is expected to report $0.92 for Q1 2024 Brown & Brown Inc. (BRO) is expected to report $1.07 for Q1 2024 Independent Bank Group Inc (IBTX) is expected to report $0.57 for Q1 2024 Burnham Holdings Inc - Class A (BURCA) is expected to report for Q1 2...
NEW YORK, NY / ACCESSWIRE / April 5, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of ARCA biopharma, Inc. (NASDAQ:ABIO) and Oruka Therapeutics is fair to ARCA shareholders. Upon closing of the proposed transaction, ARCA shareholders are expected to ow...
2024-04-05 09:06:21 ET More on ARCA biopharma ARCA biopharma to merge with Oruka Therapeutics in all-stock transaction Financial information for ARCA biopharma Read the full article on Seeking Alpha For further details see: ARCA Biopharma stock drops on C...
2024-04-05 08:29:54 ET See the biggest morning stock movers . Read the full article on Seeking Alpha For further details see: Altice USA, Genfit, Brooge Energy among premarket losers' pack
2024-04-04 10:00:16 ET More on Health Care Select Sector SPDR XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run Eli ...
2024-04-04 08:25:40 ET More on Pre-market losers & stocks. Borr Drilling: Downgrading On Potential Saudi Aramco Jackup Market Impact Borr Drilling: Fundamentals Remain Strong Ecopetrol Pays Out 18% Yield With Successful Permian Play And Gas Exploration Am...
A look at the top 10 most actives in the United States Kintara Therapeutics Inc. (KTRA) rose 63.3% to $0.164 on volume of 223,092,889 shares C3is Inc. (CISS) rose 24.2% to $0.0508 on volume of 148,576,579 shares Nikola Corporation (NKLA) fell 8.4% to $0.8918 on volume of 128,870,418 share...
2024-04-03 11:38:38 ET Arca Biopharma Inc (NASDAQ: ABIO) more than doubled on Wednesday after announcing a merger agreement with Oruka Therapeutics. Oruka CEO comments on Arca Biopharma stock deal The combined company following completion of the all-stock transaction will operat...
ARCA Biopharma, Inc. (NASDAQ: ABIO) is one today's most active stocks by volume. So far today, approximately 46.54M shares of ARCA Biopharma, Inc. have been exchanged, as compared to an average 30-day volume of 26,286 shares. ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, de...
2024-04-03 10:00:34 ET More on Health Care Select Sector SPDR XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run Eli ...
News, Short Squeeze, Breakout and More Instantly...
Several stocks with high short interest rallied on Monday following an incredible surge in GameStop Corp (NYSE:GME) shares. Here’s a quick lo...
ARCA biopharma and Oruka Therapeutics announce Merger Agreement ARCA biopharma appoints Thomas Keuer as President WESTMINSTER, Colo., April 25,...